Ruidi Dr. ADR Sees Boost: FactSet Survey Reveals Revised EPS Estimate of 0.83 Yuan and Target Price of 16.09 Yuan
Dr. Reddy’s ADR (RDY-US) 2025 EPS Estimate Revised to 0.83 Yuan
According to a recent FactSet survey, a total of 31 analysts have estimated the 2025 EPS for Dr. Reddy’s ADR (RDY-US) to be 0.83 Yuan, with a high estimate of 0.96 Yuan and a low estimate of 0.46 Yuan. The estimated target price is 16.09 Yuan.
Market Forecast EPS
| Approximate Value | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Maximum Value | 0.96 (0.94) | 0.98 | 1.11 | 0.77 |
| Minimum Value | 0.46 (0.49) | 0.59 | 0.56 | 0.77 |
| Average Value | 0.82 (0.81) | 0.82 | 0.71 | 0.77 |
| Median | 0.83 (0.84) | 0.83 | 0.68 | 0.77 |
Market Forecast Revenue
| Approximate Value | 2025 | 2026 | 2027 |
|---|---|---|---|
| Maximum Value | 3.944 billion | 4.47 billion | 4.444 billion |
| Minimum Value | 3.118 billion | 3.478 billion | 3.48 billion |
| Average Value | 3.778 billion | 4.101 billion | 3.995 billion |
| Median | 3.814 billion | 4.131 billion | 3.982 billion |
Historical Profit Performance
| Project | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EPS | 0.07 | 0.06 | 0.08 | 0.14 | 0.16 |
| Operating Income | 2.462 billion | 2.556 billion | 2.877 billion | 3.059 billion | 3.372 billion |
Source: FactSet, data is for reference only and does not serve as investment advice.